The delivery of a pharmaceutical care programme can lead to improvements in symptoms and QOL for patients with heart failure

Author：  

Publisher： Adis International

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.487, 2005-01, pp. : 13-13

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A multidisciplinary cardiac rehabilitation programme can improve symptoms, functional performance and QOL among elderly patients with heart failure

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 478, 2005-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Valsartan can reduce the combined mortality and morbidity risk in patients with heart failure

By  

Inpharma, Vol. 1, Iss. 1318, 2001-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

Intravenous diuretic day-care treatment for patients with heart failure

By Banerjee P   Tanner G   Williams L  

Clinical Medicine, Vol. 12, Iss. 2, 2012-04 ,pp. : 133-136

Royal College Of Physicians

Access to resources Recommend Favorite

Omapatrilat, enalapril similar improvements in heart failure

By  

Inpharma, Vol. 1, Iss. 1501, 2005-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite

Prognostic Significance of T-Wave Amplitude in Lead aVR in Heart Failure Patients with Narrow QRS Complexes

By Okuda Kentarou   Watanabe Eiichi   Sano Kan   Arakawa Tomoharu   Yamamoto Mayumi   Sobue Yoshihiro   Uchiyama Tatsushi   Ozaki Yukio  

Annals of Noninvasive Electrocardiology, Vol. 16, Iss. 3, 2011-07 ,pp. : 250-257

Blackwell Publishing

Access to resources Recommend Favorite